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INTRODUCTION 
Dry eye disease (DED) and ocular surface disorders may be cau sed 
or worsened by viral agents. There are several known and suspected 
virus associated to DED(1-3). The pathogenic mechanisms and thera-
peutic approach for virus-related DED are reviewed herein.
The ocular surface comprises a unique and vital component of vi-
sion. The interface composed by cornea transparency and the tear film 
is a major refractive surface of the visual system(4-6). All components of 
the ocular surface are intrinsic linked by the continuity of the epithelia 
to the tear film and by the reflex innervation and the endocrine, vas-
cular and immune systems. The synergic function of the ocular surface 
components and the harmonic influence of the sensory and motor 
nerves, hormones and fluids are responsible for the maintenance of a 
regular, comfortable and perfect refractive surface(7-9). In this context, 
viral infections might cause direct damage to the ocular surface, such 
as herpes virus or indirectly through interference in lacrimal gland 
function.
DED is a widely prevalent and multifactorial disorder involving 
multiple interacting mechanisms and a great range of signs and 
symptoms. Dysfunction of any component of the ocular surface and/
or tear film can lead to dry eye causing lower tear secretion, altera-
tions in its composition and distribution and eventually leading to 
epithelial damage and inflammation(4). 
Sjögren syndrome is one of the most complicated forms of DED. 
It is a chronic disease affecting exocrine glands, mainly lacrimal and 
salivary ones, but also organs and systems can be involved. It is cha-
racterized by an aggressive lymphocytic infiltration and circulating 
autoantibodies that lead to damage and dysfunction of glands and 
target organs(1). Although the pathogenesis of Sjögren Syndrome 
is considered a multifactorial process, it has been postulated that 
some viral infection could play a significant role on initiating and/or 
perpetrating the autoimmune response(10).
Viruses can trigger autoimmune reactions through several me -
chanisms affecting different tissues in both animal models and 
humans. Virus infection can induce neoantigen expression due to 
molecular mimicry between viral and host antigens resulting in the 
production of autoantibodies, cytotoxic T-cell or both directed to 
different host tissues(11). Once the innate immune response is ini-
tiated in glandular and dendritic cells there is an up-regulation of 
adhesion proteins and an increased production of chemokines that 
become activated and start acting as antigen-presenting cells. Those 
events could eventually lead to overproduction of immunoglobulins, 
autoantibodies and memory lymphocytes and subsequently tissue 
damage and dysfunction due to apoptosis and inflammation(12).
The occurrence of Sjögren syndrome-like illness, reported as dry eye 
symptoms or signs, in patients having confirmed viral infections, such 
as human T-cell lymphotropic virus (HTLV), human immunodeficien cy 
virus (HIV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV), as well 
as the beneficial effect of anti-viral treatment, brings circumstantial 
evi dence that their mechanism maybe pathogenically associated(3,13).
The aim of this review is to summarize the knowledge on the role 
of virus infection in the pathogenesis of DED, plausible mechanisms 
and implications for diagnosis and therapeutic strategies.
Viral infections related do dry eye
The best-studied viral agents related to systemic infection and 
DED manifestation are HTLV, HIV, HCV and EBV. Table 1 shows major 
characteristics of those viruses.
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ABSTRACT
Dry eye disease and ocular surface disorders may be caused or worsened by viral 
agents. There are several known and suspected virus associated to ocular surface 
diseases. The possible pathogenic mechanisms for virus-related dry eye disease are 
presented herein. This review serves to reinforce the importance of ophthalmo-
logists as one of the healthcare professional able to diagnose a potentially large 
number of infected patients with high prevalent viral agents.
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RESUMO
A síndrome do olho seco e as doenças de superfície ocular podem ser causadas ou agra-
vadas por agentes virais. Diversos vírus são causadores ou tem associação suspeitada 
com as doenças de superfície ocular. Esta revisão apresenta os possíveis mecanismos 
patogênicos envolvidos no olho seco causado por infecões virais e reinforça a impor-
tância do oftalmologista como um dos profissionais de saúde capazes de diagnosticar 
um grande número de pacientes infectados por agentes virais altamente prevalentes.
Descritores: Síndromes do olho seco; Infecções oculares virais; Infecções oculares
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The potential pathogenic mechanisms to DED associated to the 
viral infection in the lacrimal gland are the following: 
HtlV
The human T-cell lymphotropic virus (HTLV) infection is endemic 
in Japan, the Caribbean basin, Central and South America and Africa. 
It is transmitted through sexual intercourse, breast-feeding, blood 
transfusion and sharing of contaminated syringes and needles. HTLV 
is characterized by asymptomatic infection in most of seropositive 
cases. Although 90% of the approximately 20 million infected peo-
ple worldwide remain asymptomatic carriers during their lives, HTLV 
infection is also associated with systemic and ocular complications(14). 
HTLV infection is etiologically linked to two potential fatal 
diseases: 1) the malignant proliferation of T cell causing the adult 
leukemia/lymphoma (ATL) and 2) a neuromyelopathy known as 
tro pical spastic paraparesis (TSP). ATL is considered an aggressive lym -
phoproliferative malignancy with short survival in its acute form, 
occurring in less than 5% in HTLV infected people. TSP is a chronic 
meningomyelitis in the spinal cord, with demyelination and axonal 
degeneration leading to the development of a slowly progressive 
spastic paraparesis, high impairment of gait, autonomic dysfunction 
and profound repercussions on abilities and quality of life of the 
patients(15,16). HTLV also causes dermatitis, pneumonia, polymyositis, 
thyroiditis and Sjögren’s like syndrome(16).
HTLV ocular lesions may present as uveitis, dry eye, keratitis and 
retinal vasculitis(17). The prevalence of uveitis is controversial in diffe-
rent parts of the world. In Japan, for instance, a 35.4% prevalence of 
uveitis in patients infected with HTLV was observed, while in Martini-
que, the prevalence was 14.5%(18). The incidence of dry eye in seropo-
sitive patients was 36.4% in study conducted in the region of highest 
prevalence of HTLV infection in Brazil. Moreover, 54.4% of DED in TSP 
patients and 20.3% in asymptomatic seropositives. In those patients 
immunophenotyping analysis shown high levels of both CD4+ and 
CD8+(19). Another study, evaluating 200 infected patient found 37% of 
DES accompanied by lymphoplasmocytoid infiltration of secondary 
salivar gland(20,21).
Serological studies demonstrated the prevalence of antibodies 
to HTLV in Sjögren patients ranging from 23-36%, significantly higher 
than that among blood donors. Salivary IgA antibodies to HTLV were 
found in seropositive HTLV patients with SS(22,23). Indeed, two inde-
pendent studies confirmed the presence of HTLV genome in salivary 
glands samples from patients with Sjögren(24,25).
HiV
HIV (human immunodeficiency virus) infection may present with 
a large variety of primary and secondary (caused by opportunistic 
infections) ocular manifestations, some of those have threatening 
potential to vision and life quality. The incidence and presentation of 
the AIDS epidemic and its correlated complications have dramatically 
changed since the introduction of the potent antiretroviral therapies 
(also know as highly active antiretroviral therapy, or HAART), but 
remains as a dramatic public health in very low income countries.
DED appears to be much more prevalent among individuals with 
AIDS (21.4-38.8% of HIV-infected men, 16.9% of HIV-infected women) 
than in the general population(13,26,27). Burtin et al. evaluated the ocular 
surface and DED complains in a group of HIV positive patients. Accor-
ding to this study, 70% of them had complained of DED symptoms, 
85% present at least one clinical sign of ocular surface dysfunction 
tested through Schirmer test, tear break-up time and lissamine stain 
and the impression cytology revealed a decrease in the number of 
dendritic cells(28). 
Geier et al. showed that decreased tear production occurs in 
ap proximately 20% to 25% of patients with HIV infection without 
correlation with the CD4+v lymphocites blood count, or to the se-
verity of HIV disease, in a group of 144 HIV patients(29). Although the 
entire pathogenesis of the aqueous tear deficiency in HIV-infected 
remain unclear, it may be associated with lymphocytic infiltration and 
destruction of the lacrimal gland acini and ducts. 
In fact, a Sjögren’s syndrome-like picture may be present in HIV 
-infected patients who develop the diffuse infiltrative lymphocytosis 
syndrome (DILS). Thus, it is an exclusion criteria for individuals under 
investigation for Sjögren syndrome(30). DILS is a disorder in patients 
with HIV infection that is characterized by the enlargement of salivary 
and lacrimal glands and a varying intensity of DED symptoms. In addi-
tion, DILS is accompanied by persistent circulating and infiltration of 
CD8-positive lymphocytes. DILS may mimic Sjögren’s syndrome in 
 Table 1. Major characteristics of virus associated to dry eye disease 
Virus Type Major clinical manifestation
Major ocular  
manifestation Transmission
HTLV Retrovirus (Oncornavirus) Adult T-cell leukemia/lymphoma
Neuromyelopathy
Uveitis
Dry eye
Blood and blood products transfusion, 
breastfeeding; sexual intercourse
HIV Retrovirus (Lentivirus) Acquired immunodeficiency syndrome Dry eye Sexual intercourse; blood and blood products 
transfusion; maternal fetal; injection drug users; 
HCV RNA virus
(Flavivirus)
Hepatitis
Cirrhosis
Liver failure
Hepatocellular carcinoma
Extrahepatic manifestations (e.g. glandular, renal, 
dermatological, hematological, joints) 
Retinopathy
Scleritis
Keratitis
Dry eye
Injection drug users; blood and blood products 
transfusion; needlestick injuries in health care 
settings; sexual intercourse (rare); maternal fetal 
(rare); contaminated needles and instruments 
(tattoo, piercings) 
EBV DNA virus (Herpesvirus) Infectious mononucleosis
Burkitt’s lymphoma
Nasopharingeal carcinoma
Dry eye Exchanging of saliva
Direct contact
HSV-1 DNA virus (Herpesvirus) Mucocutaneous lesions  
(typical oral and skin watery blisters)
Meningitis, encephalitis, Bell’s palsy
Keratitis
Blepharitis
Conjunctivitis
Uveitis
Retinitis
Direct contact
HTLV= human T-cell lymphotropic virus; HIV= human immunodeficiency virus; HCV= hepatitis C virus; EBV= Epstein-Barr virus; HSV-1= herpes simplex virus-1.
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terms of symptoms and parotid and lacrimal glands involvement. On 
the other hand, it differs by the high frequency of extra glandular sites 
of lymphocytic infiltration, such as lungs, muscles and liver, scarcity 
or absence of serum autoantibodies and the nature of infiltrating 
lymphocytes. While in Sjögren syndrome presents lymphocytic infil-
tration of CD4+ and in DILS it is a CD8+ lymphocytes and anti-Ro and 
anti-La are seen less frequently(2,31). The prevalence of DILS had drop-
ped significantly after the introduction of HAART, indirectly inferring 
that the HIV infection contributes to DILS pathogenesis. 
Hepatitis c
Hepatitis C virus (HCV) is frequently associated with autoimmu-
ne features and extra hepatic manifestations, especially with chronic 
infection(32). The prevalence of HCV infection in patients with primary 
SS have been analyzed in different studies and its is comparatively 
higher than in the general population although varying geographi-
cally(3,33,34).
Ocular manifestations such as retinopathy, scleritis and keratitis 
have been well documented(35). Cacoub et al. evaluating a group of 
312 HCV patients found xerostomia and/or xeroftalmia symptoms in 
10%(36) which makes the ocular surface one of the most important 
sites of manifestations in HCV infected patients(37).
Both entities, Sjögren syndrome and HCV, are characterized by 
B-cell hyperactivity although related to different etiologies, autoim-
mune and infectious respectively. HCV have demonstrated capability 
to infect and replicate in the salivary and lacrimal gland tissues lea-
ding to lymphocytic infiltration, signs and symptoms of SS. Patients 
with Sjögren syndrome associated to HCV infection have demogra-
phic, immunological and clinical different profiles. Comparatively, 
Sjögren syndrome-HCV patients are older aged, higher incidence of 
extra glandular manifestations, especially cryoglobulinemia, and 
have negative Ro/La antibodies and hypocomplementemia. 
Again the American European criteria for Sjögren syndrome, ex-
clude Sjögren diagnosis in patients who are HCV positive(30).
eBV
EBV (Epstein Barr virus) is herpes virus that infects epithelial cell 
located in oropharyngeal tissues, salivary glands and B-lymphocytes. 
The virus occurs worldwide and most people become infected 
with EBV during the first two decades of life. In the United States, as 
many as 95% of adults between 35 and 40 years of age have been 
infected. Primary EBV infection is usually asymptomatic and resolves 
spontaneously. Occasionally, EBV infection may cause infectious 
mononucleosis characterized by fever, pharyngitis and general lym-
phadenopathy(38). After the primary infections it remains latent and 
occasionally reactivates in salivary glands(39). EBV infection of B cell 
activates intrinsic pathway that results on continuous cellular division 
and consequently lymphoproliferation.
There is increasing evidence suggesting that EBV infection may 
be related to lacrimal gland lymphocytic proliferation of Sjögren 
syndrome, which leads to decreased aqueous tear production and 
severe DED(40,41). Many studies have reported primary Sjögren syn-
drome development immediately after serological confirmation of 
infectious mononucleosis(42-44). EBV genome has been amplified from 
the majority of lacrimal gland biopsies of Sjögren patients postula-
ting that EBV may be considered a risk factor for the lacrimal gland 
pathologic mechanisms of Sjögren syndrome(43). Salivary and lacrimal 
glands differ in the type of EBC infection observed in biopsies from 
Sjögren patients. Minor salivary gland shows CD4 T cells infiltration 
and less severe inflammation. On the other hand, in lacrimal gland 
biopsies the infiltrating cell type is predominately B-lymphocytes and 
EBV antigen and EBV DNA are detected in ductal epithelia associated 
high levels of lymphoproliferation surrounding infected ducts or 
focci replacing secretory acini(45). 
HsV and ocular surface
HSV-1 (herpes simplex virus-1) ocular infection is a common 
cau se of ocular surface disorder. It can present in a broad range of 
manifestations from primary blepharoconjuntivitis to recurrent forms 
of keratitis and even intraocular involvement as that seen in retinitis 
and uveitis(46,47). Although there is no evidence of HVS direct infection 
in the lacrimal gland it has been demonstrated that corneal sensa-
tion and tear production are significant lower in patients with ocular 
herpetic disease(48,49). 
CONCLUSIONS 
Circumstantial evidence suggests that systemic and ocular viral 
infections, along with many environmental and other risks factors, 
may play an important role in the pathogenesis of dry eye disease. 
Patients with moderate to severe dry eye disease and other clinical 
manifestations should be investigated by serology of mentioned 
viral systemic infections. Many studies confirmed the association of 
viruses and lacrimal gland dysfunction and many others have been 
addressed efforts to the understanding its mechanisms. Future re-
search should characterize this subpopulation, the application of 
diag nostic tools and the possible benefits of specific antiviral treat-
ment as a therapeutic approach for dry eye disease.
Finally, the present review reinforces the importance of ophthal-
mologists as one of the healthcare professional able to diagnose a 
potentially large number of infected patients with high prevalent 
viral agents. Moreover, it may contribute to make more widely known 
the possible association between viral infections and dry eye disease 
and the importance of including an ophthalmologic evaluation as 
part of the medical approach to patients infected with specific chro-
nic viral infections. 
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